Article

Translating a Pathology Report

It is important to have a copy of your pathology report so you have documentation of your diagnosis

By law, patients are entitled to a copy of their path­ology report, and most hospitals will provide a copy free of charge. It’s important to get a copy of the pathology report to have documentation of the diagnosis; this information will be helpful in researching the disease.

Below is a brief explanation of information found in a pathology report.

Demographics: Includes information about the patient, such as the patient’s name, age, sex and date of procedure.

Specimen: Describes the origin of the tissue samples.

Clinical history: Details the patient's medical history, covering topics such as how the patient's cancer was found.

Clinical diagnosis: Indicates the diagnosis doctors were expecting before the patient's tissue was tested.

Procedure: Explains how the tissue sample was removed.

Gross description: Details the tissue sample(s), including the size, weight and color of each sample.

Microscopic description: Describes the way the cancer cells look under the microscope and may identify tumor characteristics, including grade, tumor margins and pathologic stage.

Special tests or markers: Reports the results of tests that look for proteins, genes and how quickly the cells are growing. These findings are often contained in a separate report.

Summary: Gives a pathologic diagnosis based on the information from the entire pathology report.

Related Videos
1 expert is featured in this series.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Related Content